Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity.
BACKGROUND
Collection of exhaled breath condensate (EBC) is a safe, non-invasive method to collect droplets of the airway surface liquid and measure mediators of airway inflammation and oxidative stress, such as cysteinyl-leukotrienes (cys-LTs) and 8-isoprostane.


OBJECTIVE
The aim of our study was to investigate baseline values of inflammatory lipid mediators in EBC and their relation to asthma severity.


METHODS
Nineteen healthy subjects, 16 mild, 12 moderate and 15 severe asthmatics were studied. All subjects attended a clinic visit for spirometry and EBC collection. The concentrations of exhaled cys-LTs and 8-isoprostane were measured by means of specific enzyme immunoassays.


RESULTS
8-isoprostane levels were significantly increased in mild (49.1+/-5.2 pg/mL, p<0.001), moderate (49.7+/-5.2 pg/mL, p<0.001) and severe asthmatics (77.7+/-7.3 pg/mL, p<0.001), compared to healthy controls (16.4+/-1.6 pg/mL). Moreover, 8-isoprostane levels were significantly higher in severe compared to mild and moderate asthmatics (p<0.01). Cys-LT levels were significantly higher in moderate (34.6+/-4.4 pg/mL, p<0.05) and severe asthmatics (47.9+/-6.0 pg/mL, p<0.001), while no significant difference was found between healthy controls and mild asthmatics. 8-isoprostane levels in EBC of asthmatics strongly correlated with cys-LT levels (r=0.61, p<0.0001).


CONCLUSIONS
8-isoprostane and cys-LT are detectable in EBC of healthy subjects and their levels progressively increase in asthmatic patients according to disease severity. The correlation found between these two lipid mediators indicating a link between oxidative stress and airway inflammation.
Samitas
Konstantinos
K
7th Department of Respiratory Medicine, Sotiria General Hospital, Athens, Greece.
Chorianopoulos
Dimitrios
D
Vittorakis
Stelios
S
Zervas
Eleftherios
E
Economidou
Erasmia
E
Papatheodorou
George
G
Loukides
Stelios
S
Gaga
Mina
M
D000328:Adult; D001249:Asthma / Q000378:metabolism / Q000503:physiopathology*; D001944:Breath Tests / Q000379:methods; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D003545:Cysteine / Q000032:analysis*; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000032:analysis; D005260:Female; D005541:Forced Expiratory Volume; D006115:Greece; D006801:Humans; D007124:Immunoenzyme Techniques; D015289:Leukotrienes / Q000032:analysis*; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress; D013147:Spirometry
D015289:Leukotrienes; C112381:cysteinyl-leukotriene; C075750:8-epi-prostaglandin F2alpha; D015237:Dinoprost; D003545:Cysteine